Skip to main content
Log in

Adalimumab/secukinumab

Anaphylactic reaction and alopecia-areata

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Zhang C, et al. Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis. Clinical, Cosmetic and Investigational Dermatology 16: 2879-2883, Jan 2023. Available from: URL: https://dx.doi.org/10.2147/CCID.S430156

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/secukinumab. Reactions Weekly 1983, 19 (2023). https://doi.org/10.1007/s40278-023-49368-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-49368-9

Navigation